$ImmunityBio (IBRX.US)$ is up 40% on the week from restructu...

$ImmunityBio (IBRX.US)$ is up 40% on the week from restructuring debt and securing a loan ... they have 13 drugs in their pipeline , many of which are in late stage trials and possibility of one gaining approval soon